COPCP trisodium (Compound 7a) is a potent and selective inhibitor of the ecto-5-nucleotidase CD73. By blocking CD73-mediated adenosine production, it reduces adenosines inhibitory effects on immune cells. COPCP trisodium shows promise for cancer research.
Target:
CD73
* VAT and and shipping costs not included. Errors and price changes excepted
